Correlation Between Oncopeptides and Alligator Bioscience

Can any of the company-specific risk be diversified away by investing in both Oncopeptides and Alligator Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncopeptides and Alligator Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Oncopeptides AB and Alligator Bioscience AB, you can compare the effects of market volatilities on Oncopeptides and Alligator Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncopeptides with a short position of Alligator Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncopeptides and Alligator Bioscience.

Diversification Opportunities for Oncopeptides and Alligator Bioscience

0.79

Correlation Coefficient

Oncopeptides  Alligator Bioscience

Poor diversification

The 3 months correlation between Oncopeptides and Alligator is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Oncopeptides AB and Alligator Bioscience AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alligator Bioscience and Oncopeptides is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncopeptides AB are associated (or correlated) with Alligator Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alligator Bioscience has no effect on the direction of Oncopeptides i.e., Oncopeptides and Alligator Bioscience go up and down completely randomly.

Pair Corralation between Oncopeptides and Alligator Bioscience

Assuming the 90 days trading horizon Oncopeptides AB is expected to generate 0.72 times more return on investment than Alligator Bioscience. However, Oncopeptides AB is 1.39 times less risky than Alligator Bioscience. It trades about -0.08 of its potential returns per unit of risk. Alligator Bioscience AB is currently generating about -0.19 per unit of risk. If you would invest  216.00  in Oncopeptides AB on September 2, 2024 and sell it today you would lose (51.00) from holding Oncopeptides AB or give up 23.61% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Oncopeptides AB  vs.  Alligator Bioscience AB

Oncopeptides AB

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Oncopeptides AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Alligator Bioscience

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Alligator Bioscience AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Oncopeptides and Alligator Bioscience

The main advantage of trading using opposite Oncopeptides and Alligator Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncopeptides position performs unexpectedly, Alligator Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alligator Bioscience will offset losses from the drop in Alligator Bioscience's long position.

The idea behind Oncopeptides AB and Alligator Bioscience AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.